Stock Track | Soleno Therapeutics Plunges 8.32% in Pre-Market After TD Cowen Slashes Price Target

Stock Track02-26

Soleno Therapeutics Inc. experienced a sharp pre-market decline, with its stock plummeting 8.32% during Thursday's pre-market trading session.

The significant drop follows a notable analyst action, as TD Cowen cut its price target on Soleno Therapeutics to $85 from $120. Such a substantial reduction in valuation expectations from a major financial institution often triggers negative sentiment among investors, leading to selling pressure.

While the company recently announced a change in its financial leadership, the market's reaction appears to be dominated by the revised and lower price target, reflecting concerns or a reassessment of the company's future earnings potential or commercial prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment